fda warning letters compounded semaglutide 2024 2025 Drug Recalls and Warnings: Recalls for and Tirzepatide, Wegovy; Facility FDA Drug Recalls and Warnings:

Why Its Devastating: May be permanent even after stopping the drug Currently no cure, only symptom management Severely impacts quality of life May require years of treatment or permanent dietary changes Some patients need feeding tubes for life Legal Significance: This is the primary injury in most GLP-1 lawsuits

Thats what were going to do in the future

Addressing Peripheral Neuropathy Improved glucose control with GLP-1 drugs may slow the progression of diabetic neuropathy, a condition we frequently diagnose and manage

Since approximately 40% of type 2 diabetic patients can be expected to have delayed gastric emptying, how does this affect GLP-1 secretion

Anti-aging protection Oxidative damage accelerates aging at the cellular level

When 20610 May be Reported with an E/M Code Providers may report an E/M service on the same day as 20610 when a significant and separately identifiable evaluation is performed beyond the decision to perform the procedure